Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - AXA INVESTMENT MANAGERS: Empiric Student Property plc
-
Woodbridge Announces Sale of Custom Chemical Solutions, LLC to AAVIN Private Equity
-
Market Intelligence on Autopilot: St Mary Capital Delivers Real-Time Feed
-
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
-
Tiny nation targets climate investors to become citizens and help it change the world
-
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
-
CorMedix inc. Announces Customer Implementation
-
NFI’s New Flyer secures order from Brampton Transit for additional 55 buses
-
New Wave Announces Non-Brokered Private Placement of Units
-
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
-
NETCLASS TECHNOLOGY INC and Nanyang Institute of Social Sciences Join Forces to Explore New Paths in Smart Education
-
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
-
Vote Habit Burger’s Double Char #1, Get the #1 for $1
-
AGF Investments Announces June 2025 Cash Distributions for Certain AGF ETFs and ETF Series
-
Lottery.com Regains Nasdaq Compliance as Stock Trading Activity Soars
-
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
-
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
-
Flow Capital Announces US$1.5M Follow-On Investment in Tattle
-
Attorney Launches Squeaky Clean Solution to Messy RIA Compliance
-
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
-
Churchill Reports High-Grade Silver Results up to 395 g/t Silver at the Black Raven Property, Central Newfoundland
-
USA Rare Earth Bolsters Global Sales Effort with Appointment of Ron Fogarty as Vice President of Sales
-
New DoseSpot Analysis of 100,000 GLP-1 Prescriptions Finds That Patients Overpaid by $10.2M Collectively
-
Changes in Nokia Corporation's own shares
-
Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
-
Aya Gold & Silver Closes Credit Facility with the EBRD to Support Boumadine Development
-
Sono-Tek Receives $1.12 Million Order from Global Medical Diagnostics Company for High-Volume Coating Platform
-
ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study
-
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
-
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
-
AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models
-
Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depres
-
Vstock Transfer Announces Strategic Relationship With VOTR to Transform Shareholder Engagement and Proxy Event Management
-
Sono Group N.V.’s CEO Shareholder Update – June 2025
-
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
-
Baylin Technologies to Present at the Small Cap Growth Virtual Investor Conference June 26th
-
Renowned Biohacker Gary Brecka Adds A-GAME to His Ultimate Lifestyle
-
Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché
-
Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress
-
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
-
BCI Completes Acquisition of BBGI Global Infrastructure S.A.
-
FactSet Reports Results for Third Quarter 2025
-
Elevate Your Summer with Canada’s Leading Cannabis Brands and Products by Tilray Brands
-
OTC Markets Group Welcomes Torex Gold Resources Inc. to OTCQX
-
ATR Launches Free Logistics Program to Introduce Businesses to Cost-Effective, Secure ITAD Solutions in the Gulf Coast Region and Beyond
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
Changes in Nokia Corporation's own shares
-
OXB completes acquisition of remaining stake in US subsidiary
-
Signify share repurchase period update
-
Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
